Seeking Alpha

Cellular Bio acquires rights to cancer vaccine for lung cancer

Cellular Biomedicine (NASDAQ:CBMG) acquires the exclusive rights to CD40LGVAX, a cancer therapeutic vaccine that has shown potential efficacy for the treatment on non-small cell lung cancer (NSCLC), ...
The Harvard Crimson

Molecular and Cellular Bio Updates Receive Good Reviews

Administrators behind the revamping of Molecular and Cellular Biology did not have to wait long to gauge the popularity of their new programs, courses, and requirement changes, said Alexander F.
PR Newswire

Shanghai Cellular Biopharmaceutical Group presents first data from Phase I trial evaluating a novel CAR-T in advanced liver cancer at AACR Annual Meeting

Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular ...
Business Wire

Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicines

CAMBRIDGE, Mass. & SAN DIEGO--(BUSINESS WIRE)--Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) today announced a strategic collaboration to advance initial programs in Be ...
Business Wire

Be Bio Closes $130 Million Financing to Pioneer Engineered B Cells, a New Class of Cellular Medicines

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Be Biopharma (“Be Bio”), a pioneer in the discovery and development of Engineered B Cell Medicines (BeCM), today announced the closing of a $130 million financing, ...